Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 27.94$. Average daily volumn in 3 months 2.24M. Market cap 10.26B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 28.63$. Total volume : 873.47k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
28.63$
Change
0.42
Volume
873.47k

Previous Close28.21
Open28.39
Day Range28.19-28.73
Bid28.60 x 800
Ask28.61 x 900
Volume873.47k
Average Volume2.24M
Market Cap10.26B
Beta1.71
52 Week Range14.86-34.80
Trailing P/EN/A
Foward P/E6.01
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2020 were 8.03B an decrease(0%) over the years 2019 revenue that were of 8.6B. In 2020 the company's total earnings were -560M while total earnings in 2019 were -1.79B(-44%).


Loading ...



Organization

Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.

Bausch Health Companies Inc._logo

Market Cap:
10.26B
Revenue:
8.03B
Total Assets:
31.2B
Total Cash:
605M


News about "Bausch Health Companies Inc."

Is Bausch Health Companies Inc.โ€™s (NYSE: BHC) Stock Ready For A Price Spike?_image

Is Bausch Health Companies Inc.โ€™s (NYSE: BHC) Stock Ready For A Price Spike?

In the last trading session, 5.0 million shares of the Bausch Health Companies Inc. (NYSE:BHC) were traded, and its beta was 1.70. Most recently the companyโ€™s share price was $28.21, and it changed ...

Source from : marketingsentinel - 10 hours ago


Bausch Health Companies Inc. (BHC) and the Battle of Fundamentals vs. Technicals

Bausch Health Inc. (NYSE:BHC) went up by 8.04% from its latest closing price compared to the recent 1-year high of $34.80. The companyโ€™s stock price has collected -1.57% of loss in the last five ...

Source from : newsheater - 15 hours ago


Why Bausch Health Companies Stock Zoomed 8% Higher Today

Bausch Health Companies (NYSE: BHC) was a very healthy stock Wednesday. A bullish note from an analyst at an influential bank put some real zip in the shares, and they closed the day more than 8% ...

Source from : Nasdaq - 1 days ago


Bausch Health Companies Inc. (NYSE: BHC): A Good Investment At Current Prices?_image

Bausch Health Companies Inc. (NYSE: BHC): A Good Investment At Current Prices?

Bausch Health Companies Inc. (NYSE:BHC)โ€™s traded shares stood at 1.25 million during the latest session, with the companyโ€™s beta value hitting 1.69. At the last check today, the stockโ€™s price was $27.

Source from : marketingsentinel - 5 days ago


Bausch Health Companies Inc. (BHC) distance from 20-day Simple moving Average is -3.92%: What to Expect?

Letโ€™s start up with the current stock price of Bausch Health Companies Inc. (BHC), which is $27.55 to be very precise. The Stock rose vividly during the last session to $28.12 after opening rate of ...

Source from : investchronicle - 5 days ago


Bausch Health Companies Inc. (BHC) Just Got Our Attention

Bausch Health Companies Inc. (NYSE:BHC) went down by -1.82% from its latest closing price compared to the recent 1-year high of $34.80. The companyโ€™s stock price has collected -1.95% of loss in the ...

Source from : newsheater - 7 days ago


NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc.

An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was announced. Source: Shareholders Foundation, Inc ...

Source from : SBWire - 9 days ago


Investigation for Investors in shares of Bausch Health Companies Inc. (NYSE: BHC) announced over potential Wrongdoing by certain directors

Certain directors of Bausch Health Companies Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Bausch Health Companies Inc. (NYSE ...

Source from : openpr.com - 12 days ago


Bausch Health Companies Inc. (NYSE: BHC) Shares Rose Recently, But Trouble Could Still Be Around The Corner.

Bausch Health Companies Inc. (NYSE:BHC) price closed lower on Tuesday, September 14, dropping -1.82% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-P ...

Source from : stocksregister - 7 days ago


Bausch Health Companies Inc BHC

While Bausch Healthโ€™s second-quarter results were slightly ... considering the one-time impact from the divestiture of Egyptian pharmaceutical company Amoun, which will reduce sales by $120 ...

Source from : Morningstar%2c Inc. - 9 days ago


Bausch Health Announces Participation In Upcoming Investor Conferences

1, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in multiple upcoming investor conferences.

Source from : Business Insider - 21 days ago


Bausch Health Cos. Inc.

1 Day BHC 3.02% DJIA 0.69% S&P 500 0.88% Health Care/Life Sciences -0.49% Joseph C. Papa Chairman & Chief Executive Officer Prometheus Biosciences, Inc, Bausch Health Cos., Inc. Brett M.

Source from : Wall Street Journal - 27 days ago


DJ Bausch Health Cos. Inc. Stock Falls Thursday, Underperforms Market

Dow Jones & Company, Inc. This article was automatically generated by MarketWatch using technology from Automated Insights.

Source from : Sharecast - 6 days ago


Bausch Health files confidentially for IPOs of eye care business and medical aesthetics business

Inc. said Monday it has filed confidentially for the initial public offerings of its eye health business Bausch & Lomb, and its medical aesthetics business Global Solta. The company has not yet ...

Source from : Business Insider - 8 days ago


Bausch Health Companies Inc.: Bausch Buoyed by Rebounding Eyecare Despite Delta-Variant Risk, B+L Spin Likely a Year Away

Formerly known as Valeant Pharmaceuticals, Bausch Health ... Morningstar, Inc. He contributes primarily to the research coverage of South American banks and Canadian insurance companies and ...

Source from : Yahoo Finance - 14 days ago


Anaqua Delivers Enhanced IP Management to Bausch Health

BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property management technology provider, today announced that Bausch Health Companies Inc. has selected ...

Source from : Benzinga.com - 8 days ago


Intraocular Lens Market Strategic Assessment, Growth Analysis and Research Outlook 2021-2026| Novartis AG (Alcon), Bausch Health Companies Inc

Top Companies like Novartis AG (Alcon), Bausch Health Companies Inc. (Bausch + Lomb), Carl Zeiss Meditec AG, EyeKon Medical Inc., HOYA CORPORATION, HumanOptics AG, Johnson and Johnson Vision Care ...

Source from : openpr.com - 13 days ago


Global Ophthalmology Medical Device Market Competition, Opportunities and Challenges Market Players (Bausch & Lomb Inc.)2022-2027

The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies ... the globe with the World Health Organization declaring ...

Source from : MarketWatch - 12 days ago


Bausch Health Companies Inc BHC

While Bausch Healthโ€™s second-quarter results were slightly ... considering the one-time impact from the divestiture of Egyptian pharmaceutical company Amoun, which will reduce sales by $120 ...

Source from : Morningstar%2c Inc. - 13 days ago


Anaqua Delivers Enhanced IP Management to Bausch Health

BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property management technology provider, today announced that Bausch Health Companies Inc. has selected ...

Source from : Yahoo Finance - 8 days ago


Activist Spotlight: Activists In Bausch Health With Catalysts On Horizon

Comparables like Cooper Companies and Alcon Inc. are currently trading between ... the total value of Bausch Health using sum-of-the-parts method, net of debt, should be worth north of $35 per ...

Source from : Seeking Alpha - 21 days ago


Aesthetic Laser and Energy Device Market May Set New Growth Story by 2031 | Hologic (Cynosure), Bausch Health Companies (Solta Medical), Lumenis

Pune, Maharashtra, India, August 30 2021 (Wiredrelease) Prudour Pvt. Ltd โ€“:The term Aesthetic Laser and Energy Device market value is expected to gain significant momentum, where the market is ...

Source from : Digital Journal - 23 days ago


Bausch Health Companies Inc (BHC) NPV

The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of ...

Source from : Hargreaves Lansdown - 6 days ago


TSX:BHC (Bausch Health Companies)

Because of high debt, a money-losing partnership, and questions about whether or not insiders have faith, I say avoid Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE ...

Source from : The Motley Fool Canada - 15 days ago


Eye Health Supplements Market Global Key Players, Emerging Industry Trends and Forecast to 2028| Bausch & Lomb, Vitabiotics, Pfizer, Alliance Pharma

The Global Eye Health Supplements Market is anticipated to grow strongly at a significant growth rate during the forecast period. The most recent research report Global Eye Health Supplements Market ...

Source from : manometcurrent.com - 14 days ago


Bausch Health Companies Inc. (NYSE:BHC) Is Expected To Breakeven In The Near Future

Bausch Health Companies Inc. (NYSE:BHC) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Bausch Health Companies Inc. develops, ...

Source from : Yahoo News - 1 month ago


Bausch Health Companies Inc. Announces Second-Quarter 2021 Results

As of June 30, 2021, Cash and cash equivalents excludes $62 million of cash and cash equivalents classified as held for sale associated with the Company's sale of its equity interests in Amoun ...

Source from : WFMZ-TV - 1 month ago


Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical

Bausch Health Companies Inc. (TSX:BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical ...

Source from : Benzinga.com - 1 month ago


Bausch Health To Reduce Debt By $350 Million

LAVAL, Quebec, Aug. 3, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $350 million through the redemption ...

Source from : Stockhouse - 1 month ago


Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

LAVAL, QC, July 6, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2021 financial results on Tuesday, Aug. 3, 2021. Bausch Health will host ...

Source from : Yahoo Canada Sports - 2 month ago


Bausch Health Cos. Inc. stock rises Tuesday, outperforms market

Bausch Health Cos. Inc. closed C$9.14 short of its 52-week high (C$43.97), which the company reached on March 9th. Trading volume of 400,766 shares eclipsed its 50-day average volume of 377,238.

Source from : MarketWatch - 1 month ago


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Aug. 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. ("Bausch or the "Company") (NYSE: BHC). Such investors are advised ...

Source from : Yahoo Finance - 1 month ago


Paroxysmal Choreoathetosis Market SWOT Analysis

The Paroxysmal Choreoathetosis Market Report conveys the clean expounded structure of the Market including every single business-related data of the market at a worldwide level. The total scope of ...

Source from : PharmiWeb - 1 month ago


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

New York, New York--(Newsfile Corp. - August 9, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. ("Bausch or the "Company") (NYSE: BHC). Such ...

Source from : Yahoo Finance - 1 month ago


Bausch Health Cos. Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 1 month ago


Global Chemical Peel Market (2021 to 2025) - Featuring AbbVie, Bausch Health Companies and L'Oreal Among Others

this report provides a detailed analysis of several leading chemical peel market vendors that include AbbVie Inc., Bausch Health Companies Inc., Colgate-Palmolive Co., Johnson and Johnson Inc., LOreal ...

Source from : Yahoo Finance - 1 month ago


TSX:BHC (Bausch Health Companies)

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Westport Innovations Inc. (TSX:WPT)(NASDAQ:WPRT), and Sierra Wireless Inc. (TSX:SW)(NASDAQ:SWIR) deserve a spot in your portfolio. More ยป ...

Source from : The Motley Fool Canada - 1 month ago


Bausch Health Cos. Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 1 month ago